Chickenpox vaccine could lead to less flesh-eating disease but more shingles
From: JWissmille (jwissmille_at_aol.com)
Date: 01/02/05
- Next message: JWissmille: "TIck problem reaches peak after storms"
- Previous message: JWissmille: "Editorial: Industry Distortion of the F.D.A."
- Messages sorted by: [ date ] [ thread ]
Date: 02 Jan 2005 01:18:20 GMT
http://www.canada.com/health/story.html?id=88dba609-3b8b-43f7-8e4a-34bf438e9
f45
Canada.com News
Chickenpox vaccine could lead to less flesh-eating disease but more shingles
Helen Branswell
Canadian Press
Tuesday, December 07, 2004
MONTREAL (CP) - Wider use of chickenpox vaccine could produce two
side-effects, one a blessing and the other a curse, infectious disease
experts said Monday.
On the positive side, there would likely be fewer cases of flesh-eating
disease in young children. On the negative side, there could be higher rates
of shingles among adults.
Experts gathered at an immunization conference in Montreal were enthusiastic
about the varicella vaccine. In addition to eliminating the misery of itchy
chickenpox, wide use of the vaccine would cut the 300 to 350
hospitalizations a year the disease provokes across Canada, as well as the
risk of a child developing life-threatening necrotizing fasciitis, they
said.
A study presented at the conference showed that between September 2001 and
August 2003, 37 children in Canada had flesh-eating disease and two of them
died. In 61 per cent of the cases, the children had chickenpox - a known
risk factor - in the month before developing necrotizing fasciitis.
Most of the affected children were under one year old, meaning they were too
young to have been vaccinated against varicella, the scientific name for
chickenpox, said Dr. Danielle Grenier, medical affairs officer for the
Canadian Pediatric Society, one of the co-sponsors of the conference.
But if enough children over one year old are vaccinated, the amount of
circulating virus - and the risk to younger children - will drop
dramatically, a phenomenon known as herd immunity.
"We could prevent not only necrotizing fasciitis, but also prevent the other
complications of varicella," Grenier said.
"But if we get herd immunity, it would also protect the little ones, the
ones that were most severely affected by this."
Currently only Alberta, Ontario, New Brunswick, Nova Scotia, Prince Edward
Island, Northwest Territories and Nunavut provide varicella vaccine for free
as part of their pediatric vaccination programs.
But increased use of the vaccine in children could come at a cost to adults
who had chickenpox earlier in their lives.
The varicella virus doesn't leave one's system, but rests in a latent state
in nerve cells. For some people, it stays that way. But in others, the virus
becomes reactivated later in life, causing a painful condition called herpes
zoster - more commonly known as shingles.
It's believed that adults who have intermittent exposure to wild chickenpox
virus get what amounts to a natural booster shot.
If widespread use of varicella vaccine dramatically reduces the amount of
circulating wild virus, immunity to the virus could wane in adults and more
people could have flare-ups of shingles, it is believed.
"At this point virtually every Canadian adult has had real chickenpox, so a
quarter of us will be expected to get shingles at some point. So that may go
up without wild virus circulating," said Dr. David Scheifele, director of
the vaccine evaluation centre at B.C. Children's Hospital.
The condition isn't just painful, it is costly.
Data presented at the conference by pharmaceutical manufacturer Merck Frost,
which markets a varicella vaccine, suggest there are about 130,000 cases of
shingles a year in Canada and they cost the health care system somewhere
between $39 million and $82 million a year.
Dr. Barb Law insisted it isn't clear how much protection adults get from
exposure to wild virus versus how much comes from their own immune systems.
Still, Law - an infectious disease expert from the University of Manitoba
and a leading proponent of the varicella vaccine - acknowledged the risk of
a 20 per cent rise in shingles cases exists.
But she doesn't believe it should get in the way of the pediatric
immunization program.
"To me, it's absolutely not a reason not to start immunizing, because
there's a burden with chickenpox with children."
And the risk may be lowered, Law and Scheifele noted, by the introduction in
the not-too-distant future of an adult chickenpox booster shot.
Vaccine manufacturers have been studying the efficacy of giving adults a
varicella booster as a means of preventing shingles. Findings are expected
to be published sometime next year.
- Next message: JWissmille: "TIck problem reaches peak after storms"
- Previous message: JWissmille: "Editorial: Industry Distortion of the F.D.A."
- Messages sorted by: [ date ] [ thread ]
Relevant Pages
|
